Request for Covid-19 Impact Assessment of this Report

Medical Devices

COVID-19 Impact on 3D Bio-Printing Market , Global Research Reports 2020-2021

  • BMR3866676
  • 90 Pages
  • May 2020
  • Medical Devices
Download Sample    Get Discount   
 
Three dimensional (3D) bioprinting is the utilization of 3D printing and 3D printing–like techniques to combine cells, growth factors, and biomaterials to fabricate biomedical parts that maximally imitate natural tissue characteristics. Generally, 3D bioprinting utilizes the layer-by-layer method to deposit materials known as bioinks to create tissue-like structures that are later used in medical and tissue engineering fields. Bioprinting covers a broad range of biomaterials.

Rising incidences of chronic illnesses leading to organ and tissue transplants coupled with the increasing life span of individuals and limited number of organ donors are expected to be the major drivers for the market growth. The advancement in technology and incorporation of IT within the healthcare industry, rising geriatric population base, and improving R&D efforts for the sector is also expected to propel the 3D bioprinting market over the forecast period.

This report provides a complete quantitative data and qualitative analysis on the global market for 3D Bio-Printing. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.

Prior to COVID-19, the global market for 3D Bio-Printing was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for 3D Bio-Printing is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.

This report covers market size and forecasts of 3D Bio-Printing, including the following market information:

Global 3D Bio-Printing Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)

Global 3D Bio-Printing Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)

Global 3D Bio-Printing Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)

Global 3D Bio-Printing Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

Key market players

Major competitors identified in this market include Organovo, Cyfuse Biomedical, BioBots, Luxexcel Group, Aspect Biosystems, 3Dynamics Systems, Stratasys, Voxeljet, Materialise, Solidscape, etc.

Based on the Region:

Asia-Pacific (China, Japan, South Korea, India and ASEAN)

North America (US and Canada)

Europe (Germany, France, UK and Italy)

Rest of World (Latin America, Middle East & Africa)

Based on the Type:

Magnetic Levitation

Inkjet Based 3D Bioprinting

Syringe Based 3D Bioprinting

Laser Based 3D Bioprinting

Others

Based on the Application:

Medical

Dental

Biosensors

Food and Animal Product Bioprinting

Others

1.1 Research Scope

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on 3D Bio-Printing Industry

1.7 COVID-19 Impact: 3D Bio-Printing Market Trends

2 Global 3D Bio-Printing Quarterly Market Size Analysis

2.1 3D Bio-Printing Business Impact Assessment - COVID-19

2.1.1 Global 3D Bio-Printing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global 3D Bio-Printing Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global 3D Bio-Printing Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global 3D Bio-Printing Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global 3D Bio-Printing Factory Price by Manufacturers

3.3 Location of Key Manufacturers 3D Bio-Printing Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into 3D Bio-Printing Market

3.5 Key Manufacturers 3D Bio-Printing Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on 3D Bio-Printing Segments, By Type

4.1 Introduction

1.4.1 Magnetic Levitation

1.4.2 Inkjet Based 3D Bioprinting

1.4.3 Syringe Based 3D Bioprinting

1.4.4 Laser Based 3D Bioprinting

1.4.5 Others

4.2 By Type, Global 3D Bio-Printing Market Size, 2019-2021

4.2.1 By Type, Global 3D Bio-Printing Market Size by Type, 2020-2021

4.2.2 By Type, Global 3D Bio-Printing Price, 2020-2021

5 Impact of Covid-19 on 3D Bio-Printing Segments, By Application

5.1 Overview

5.5.1 Medical

5.5.2 Dental

5.5.3 Biosensors

5.5.4 Food and Animal Product Bioprinting

5.5.5 Others

5.2 By Application, Global 3D Bio-Printing Market Size, 2019-2021

5.2.1 By Application, Global 3D Bio-Printing Market Size by Application, 2019-2021

5.2.2 By Application, Global 3D Bio-Printing Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 Organovo

7.1.1 Organovo Business Overview

7.1.2 Organovo 3D Bio-Printing Quarterly Production and Revenue, 2020

7.1.3 Organovo 3D Bio-Printing Product Introduction

7.1.4 Organovo Response to COVID-19 and Related Developments

7.2 Cyfuse Biomedical

7.2.1 Cyfuse Biomedical Business Overview

7.2.2 Cyfuse Biomedical 3D Bio-Printing Quarterly Production and Revenue, 2020

7.2.3 Cyfuse Biomedical 3D Bio-Printing Product Introduction

7.2.4 Cyfuse Biomedical Response to COVID-19 and Related Developments

7.3 BioBots

7.3.1 BioBots Business Overview

7.3.2 BioBots 3D Bio-Printing Quarterly Production and Revenue, 2020

7.3.3 BioBots 3D Bio-Printing Product Introduction

7.3.4 BioBots Response to COVID-19 and Related Developments

7.4 Luxexcel Group

7.4.1 Luxexcel Group Business Overview

7.4.2 Luxexcel Group 3D Bio-Printing Quarterly Production and Revenue, 2020

7.4.3 Luxexcel Group 3D Bio-Printing Product Introduction

7.4.4 Luxexcel Group Response to COVID-19 and Related Developments

7.5 Aspect Biosystems

7.5.1 Aspect Biosystems Business Overview

7.5.2 Aspect Biosystems 3D Bio-Printing Quarterly Production and Revenue, 2020

7.5.3 Aspect Biosystems 3D Bio-Printing Product Introduction

7.5.4 Aspect Biosystems Response to COVID-19 and Related Developments

7.6 3Dynamics Systems

7.6.1 3Dynamics Systems Business Overview

7.6.2 3Dynamics Systems 3D Bio-Printing Quarterly Production and Revenue, 2020

7.6.3 3Dynamics Systems 3D Bio-Printing Product Introduction

7.6.4 3Dynamics Systems Response to COVID-19 and Related Developments

7.7 Stratasys

7.7.1 Stratasys Business Overview

7.7.2 Stratasys 3D Bio-Printing Quarterly Production and Revenue, 2020

7.7.3 Stratasys 3D Bio-Printing Product Introduction

7.7.4 Stratasys Response to COVID-19 and Related Developments

7.8 Voxeljet

7.8.1 Voxeljet Business Overview

7.8.2 Voxeljet 3D Bio-Printing Quarterly Production and Revenue, 2020

7.8.3 Voxeljet 3D Bio-Printing Product Introduction

7.8.4 Voxeljet Response to COVID-19 and Related Developments

7.9 Materialise

7.9.1 Materialise Business Overview

7.9.2 Materialise 3D Bio-Printing Quarterly Production and Revenue, 2020

7.9.3 Materialise 3D Bio-Printing Product Introduction

7.9.4 Materialise Response to COVID-19 and Related Developments

7.10 Solidscape

7.10.1 Solidscape Business Overview

7.10.2 Solidscape 3D Bio-Printing Quarterly Production and Revenue, 2020

7.10.3 Solidscape 3D Bio-Printing Product Introduction

7.10.4 Solidscape Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 3D Bio-Printing Supply Chain Analysis

8.1.1 3D Bio-Printing Supply Chain Analysis

8.1.2 Covid-19 Impact on 3D Bio-Printing Supply Chain

8.2 Distribution Channels Analysis

8.2.1 3D Bio-Printing Distribution Channels

8.2.2 Covid-19 Impact on 3D Bio-Printing Distribution Channels

8.2.3 3D Bio-Printing Distributors

8.3 3D Bio-Printing Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

List of Tables

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on 3D Bio-Printing Assessment

Table 9. COVID-19 Impact: 3D Bio-Printing Market Trends

Table 10. COVID-19 Impact Global 3D Bio-Printing Market Size

Table 11. Global 3D Bio-Printing Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)

Table 12. Global 3D Bio-Printing Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)

Table 13. Global 3D Bio-Printing Quarterly Market Size, 2020 (US$ Million) & (K Units)

Table 14. Global 3D Bio-Printing Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global 3D Bio-Printing Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)

Table 16. Global 3D Bio-Printing Market Growth Drivers

Table 17. Global 3D Bio-Printing Market Restraints

Table 18. Global 3D Bio-Printing Market Opportunities

Table 19. Global 3D Bio-Printing Market Challenges

Table 20. Key Manufacturers 3D Bio-Printing Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, 3D Bio-Printing Market Size, 2019 (K Units) & (US$ Million)

Table 22. 3D Bio-Printing Factory Price by Manufacturers 2020 (USD/Unit)

Table 23. Location of Key Manufacturers 3D Bio-Printing Manufacturing Plants

Table 24. Key Manufacturers 3D Bio-Printing Market Served

Table 25. Date of Key Manufacturers Enter into 3D Bio-Printing Market

Table 26. Key Manufacturers 3D Bio-Printing Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global 3D Bio-Printing Market Size by Type, 2020, (US$ Million)

Table 29. Global 3D Bio-Printing Market Size by Type, 2020 (K Units)

Table 30. Global 3D Bio-Printing Price: by Type, 2020-2021 (USD/Unit)

Table 31. Global 3D Bio-Printing Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global 3D Bio-Printing Market Size by Application, 2020-2021 (K Units)

Table 33. Global 3D Bio-Printing Price: by Application, 2020-2021 (USD/Unit)

Table 34. Global 3D Bio-Printing Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global 3D Bio-Printing Market Size by Region, 2019-2021 (K Units)

Table 36. By Country, North America 3D Bio-Printing Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America 3D Bio-Printing Market Size, 2019-2021 (K Units)

Table 38. US 3D Bio-Printing Market Size, 2019-2021 (US$ Million) & (K Units)

Table 39. Canada 3D Bio-Printing Market Size, 2019-2021 (US$ Million) & (K Units)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe 3D Bio-Printing Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe 3D Bio-Printing Market Size, 2019-2021 (K Units)

Table 43. Germany 3D Bio-Printing Market Size, 2019-2021 (US$ Million) & (K Units)

Table 44. France 3D Bio-Printing Market Size, 2019-2021 (US$ Million) & (K Units)

Table 45. UK 3D Bio-Printing Market Size, 2019-2021 (US$ Million) & (K Units)

Table 46. Italy 3D Bio-Printing Market Size, 2019-2021 (US$ Million) & (K Units)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific 3D Bio-Printing Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific 3D Bio-Printing Market Size, 2019-2021 (K Units)

Table 50. China 3D Bio-Printing Market Size, 2019-2021 (US$ Million) & (K Units)

Table 51. Japan 3D Bio-Printing Market Size, 2019-2021 (US$ Million) & (K Units)

Table 52. South Korea 3D Bio-Printing Market Size, 2019-2021 (US$ Million) & (K Units)

Table 53. India 3D Bio-Printing Market Size, 2019-2021 (US$ Million) & (K Units)

Table 54. ASEAN 3D Bio-Printing Market Size, 2019-2021 (US$ Million) & (K Units)

Table 55. Latin America 3D Bio-Printing Market Size, 2019-2021 (US$ Million) & (K Units)

Table 56. Middle East and Africa 3D Bio-Printing Market Size, 2019-2021 (US$ Million) & (K Units)

Table 57. Organovo Business Overview

Table 58. Organovo 3D Bio-Printing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Organovo 3D Bio-Printing Product

Table 60. Organovo Response to COVID-19 and Related Developments

Table 61. Cyfuse Biomedical Business Overview

Table 62. Cyfuse Biomedical 3D Bio-Printing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Cyfuse Biomedical 3D Bio-Printing Product

Table 64. Cyfuse Biomedical Response to COVID-19 and Related Developments

Table 65. BioBots Business Overview

Table 66. BioBots 3D Bio-Printing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. BioBots 3D Bio-Printing Product

Table 68. BioBots Response to COVID-19 and Related Developments

Table 69. Luxexcel Group Business Overview

Table 70. Luxexcel Group 3D Bio-Printing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Luxexcel Group 3D Bio-Printing Product

Table 72. Luxexcel Group Response to COVID-19 and Related Developments

Table 73. Aspect Biosystems Business Overview

Table 74. Aspect Biosystems 3D Bio-Printing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Aspect Biosystems 3D Bio-Printing Product

Table 76. Aspect Biosystems Response to COVID-19 and Related Developments

Table 77. 3Dynamics Systems Business Overview

Table 78. 3Dynamics Systems 3D Bio-Printing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. 3Dynamics Systems 3D Bio-Printing Product

Table 80. 3Dynamics Systems Response to COVID-19 and Related Developments

Table 81. Stratasys Business Overview

Table 82. Stratasys 3D Bio-Printing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Stratasys 3D Bio-Printing Product

Table 84. Stratasys Response to COVID-19 and Related Developments

Table 85. Voxeljet Business Overview

Table 86. Voxeljet 3D Bio-Printing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Voxeljet 3D Bio-Printing Product

Table 88. Voxeljet Response to COVID-19 and Related Developments

Table 89. Materialise Business Overview

Table 90. Materialise 3D Bio-Printing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Materialise 3D Bio-Printing Product

Table 92. Materialise Response to COVID-19 and Related Developments

Table 93. Solidscape Business Overview

Table 94. Solidscape 3D Bio-Printing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Solidscape 3D Bio-Printing Product

Table 96. Solidscape Response to COVID-19 and Related Developments

Table 97. 3D Bio-Printing Distributors List

Table 98. 3D Bio-Printing Customers List

Table 99. Covid-19 Impact on 3D Bio-Printing Customers

List of Figures

Figure 1. 3D Bio-Printing Product Picture

Figure 2. 3D Bio-Printing Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global 3D Bio-Printing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global 3D Bio-Printing Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global 3D Bio-Printing Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global 3D Bio-Printing Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global 3D Bio-Printing Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global 3D Bio-Printing Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450